Correlation of ErbB2 gene status, mRNA and protein expression
2006-01-01 D'Incalci, M
Reduced expression of the rock inhibitor rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells
2010-01-01 Belgiovine, Cristina; Frapolli, Roberta; Bonezzi, Katiuscia; Chiodi, Ilaria; Favero, Francesco; Mello-grand, Maurizia; Dei Tos, Angelo P.; Giulotto, Elena; Taraboletti, Giulia; D'Incalci, Maurizio; Mondello, Chiara
Pharmacokinetics of anticancer agents in patients with impaired liver function
1998-01-01 Donelli, Mg; Zucchetti, M; Munzone, E; D'Incalci, M; Crosignani, A
Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study
2009-01-01 Marangon, E; Falcioni, C; Manzotti, C; Fontana, G; D'Incalci, M; Zucchetti, M
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
2012-01-01 Mosig, Ra; Lobl, M; Senturk, E; Shah, H; Cohen, S; Chudin, E; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, Ja
Investigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticles
2014-01-01 Ferrari, R; Lupi, M; Colombo, C; Morbidelli, M; D'Incalci, M; Moscatelli, D
Idarubicin and melphalan as myeloablative regimen after sequential high dose chemotherapy for lymphomas: Preliminary results of a phase I-II study with pharmaco-kinetical guided peripheral blood progenitor cell reinfusion
1998-01-01 Cocorocchio, E; Peccatori, F; El Taani, H; Ferrucci, Pf; Cocquio, A; Agazzi, A; Corsini, C; Cinieri, S; Zucchetti, M; D'Incalci, M; Martinelli, G
PHARMACOKINETICS OF HD-MTX IN INFANTS, CHILDREN, AND ADOLESCENTS WITH NON-B ACUTE LYMPHOBLASTIC-LEUKEMIA
1995-01-01 Donelli, Mg; Zucchetti, M; Robatto, A; Perlangeli, V; D'Incalci, M; Masera, G; Rossi, Mr
Neuroprotection by erythropoietin against taxane induced peripheral neuropathy
2009-01-01 Cervellini, I; Porretta-Serapiglia, C; Bello, E; Frapolli, R; Oggioni, N; Canta, A; Meregalli, C; Lombardi, R; Ghezzi, P; Lauria, G; D'Incalci, M; Cavaletti, G; Bianchi, R
Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
1998-01-01 Sessa, C; Minoia, C; Ronchi, A; Zucchetti, M; Bauer, J; Borner, M; de Jong, J; Pagani, O; Renard, J; Weil, C; D'Incalci, M
Mechanism of action and antitumor activity of PM01183
2009-01-01 Aviles, P; Galmarini, C; Cuevas, C; Guillen, Mj; Frapolli, R; Uboldi, S; Romano, M; Tavecchio, M; Erba, E; Bello, E; D'Incalci, M
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
2017-01-01 Tassi, Ra; Todeschini, P; Siegel, Er; Calza, S; Cappella, P; Ardighieri, L; Cadei, M; Bugatti, M; Romani, C; Bandiera, E; Zanotti, L; Tassone, L; Guarino, D; Santonocito, C; Capoluongo, Ed; Beltrame, L; Erba, E; Marchini, S; D'Incalci, M; Donzelli, C; Santin, Ad; Pecorelli, S; Sartori, E; Bignotti, E; Odicino, F; Ravaggi, A
Is Aplidine acting as an ornithine decarboxylase (ODC) inhibitor?
1999-01-01 Erba, E; Bassano, L; Di Liberti, G; Muradore, I; Codegoni, Am; Celli, N; D'Incalci, M; Desiderio, A; Faircloth, Gt; Jimeno, J
Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin) - An example of potential problems for extrapolation of active drug concentrations from in vitro studies
2004-01-01 Tognon, G; Frapolli, R; Zaffaroni, M; Erba, E; Zucchetti, M; Faircloth, Gt; D'Incalci, M
Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies
2003-01-01 Meco, D; Colombo, T; Ubezio, P; Zucchetti, M; Zaffaroni, M; Riccardi, A; Faircloth, G; Jose, J; D'Incalci, M; Riccardi, R
The complexity of cell cycle dynamic of anticancer drugs unraveled by the use of mathematical models suitable for a quantitative assessment of G1, S and G2M checkpoint activities
2008-01-01 Ubezio, P; Lupi, M; Natoli, C; Colombo, V; D'Incalci, M
A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia
2006-01-01 Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M
Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft
2005-01-01 Riccardi, A; Meco, D; Ubezio, P; Mazzarella, G; Marabese, M; Faircloth, Gt; Jimeno, J; D'Incalci, M; Riccardi, R
Trabectedin as a chemotherapy option for patients with BRCA deficiency
2016-01-01 Monk, Bj; Lorusso, D; Italiano, A; Kaye, Sb; Aracil, M; Tanovic, A; D'Incalci, M
Mechanisms of resistance to alkylating agents
1998-01-01 Damia, G; D'Incalci, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Correlation of ErbB2 gene status, mRNA and protein expression | 1-gen-2006 | D'Incalci, M | |
| Reduced expression of the rock inhibitor rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells | 1-gen-2010 | Belgiovine, Cristina; Frapolli, Roberta; Bonezzi, Katiuscia; Chiodi, Ilaria; Favero, Francesco; Mello-grand, Maurizia; Dei Tos, Angelo P.; Giulotto, Elena; Taraboletti, Giulia; D'Incalci, Maurizio; Mondello, Chiara | |
| Pharmacokinetics of anticancer agents in patients with impaired liver function | 1-gen-1998 | Donelli, Mg; Zucchetti, M; Munzone, E; D'Incalci, M; Crosignani, A | |
| Development and validation of a LC-MS/MS method for the determination of the novel oral 1,14 substituted taxane derivatives, IDN 5738 and IDN 5839, in mouse plasma and its application to the pharmacokinetic study | 1-gen-2009 | Marangon, E; Falcioni, C; Manzotti, C; Fontana, G; D'Incalci, M; Zucchetti, M | |
| IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer | 1-gen-2012 | Mosig, Ra; Lobl, M; Senturk, E; Shah, H; Cohen, S; Chudin, E; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, Ja | |
| Investigation of size, surface charge, PEGylation degree and concentration on the cellular uptake of polymer nanoparticles | 1-gen-2014 | Ferrari, R; Lupi, M; Colombo, C; Morbidelli, M; D'Incalci, M; Moscatelli, D | |
| Idarubicin and melphalan as myeloablative regimen after sequential high dose chemotherapy for lymphomas: Preliminary results of a phase I-II study with pharmaco-kinetical guided peripheral blood progenitor cell reinfusion | 1-gen-1998 | Cocorocchio, E; Peccatori, F; El Taani, H; Ferrucci, Pf; Cocquio, A; Agazzi, A; Corsini, C; Cinieri, S; Zucchetti, M; D'Incalci, M; Martinelli, G | |
| PHARMACOKINETICS OF HD-MTX IN INFANTS, CHILDREN, AND ADOLESCENTS WITH NON-B ACUTE LYMPHOBLASTIC-LEUKEMIA | 1-gen-1995 | Donelli, Mg; Zucchetti, M; Robatto, A; Perlangeli, V; D'Incalci, M; Masera, G; Rossi, Mr | |
| Neuroprotection by erythropoietin against taxane induced peripheral neuropathy | 1-gen-2009 | Cervellini, I; Porretta-Serapiglia, C; Bello, E; Frapolli, R; Oggioni, N; Canta, A; Meregalli, C; Lombardi, R; Ghezzi, P; Lauria, G; D'Incalci, M; Cavaletti, G; Bianchi, R | |
| Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days | 1-gen-1998 | Sessa, C; Minoia, C; Ronchi, A; Zucchetti, M; Bauer, J; Borner, M; de Jong, J; Pagani, O; Renard, J; Weil, C; D'Incalci, M | |
| Mechanism of action and antitumor activity of PM01183 | 1-gen-2009 | Aviles, P; Galmarini, C; Cuevas, C; Guillen, Mj; Frapolli, R; Uboldi, S; Romano, M; Tavecchio, M; Erba, E; Bello, E; D'Incalci, M | |
| FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients | 1-gen-2017 | Tassi, Ra; Todeschini, P; Siegel, Er; Calza, S; Cappella, P; Ardighieri, L; Cadei, M; Bugatti, M; Romani, C; Bandiera, E; Zanotti, L; Tassone, L; Guarino, D; Santonocito, C; Capoluongo, Ed; Beltrame, L; Erba, E; Marchini, S; D'Incalci, M; Donzelli, C; Santin, Ad; Pecorelli, S; Sartori, E; Bignotti, E; Odicino, F; Ravaggi, A | |
| Is Aplidine acting as an ornithine decarboxylase (ODC) inhibitor? | 1-gen-1999 | Erba, E; Bassano, L; Di Liberti, G; Muradore, I; Codegoni, Am; Celli, N; D'Incalci, M; Desiderio, A; Faircloth, Gt; Jimeno, J | |
| Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin) - An example of potential problems for extrapolation of active drug concentrations from in vitro studies | 1-gen-2004 | Tognon, G; Frapolli, R; Zaffaroni, M; Erba, E; Zucchetti, M; Faircloth, Gt; D'Incalci, M | |
| Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies | 1-gen-2003 | Meco, D; Colombo, T; Ubezio, P; Zucchetti, M; Zaffaroni, M; Riccardi, A; Faircloth, G; Jose, J; D'Incalci, M; Riccardi, R | |
| The complexity of cell cycle dynamic of anticancer drugs unraveled by the use of mathematical models suitable for a quantitative assessment of G1, S and G2M checkpoint activities | 1-gen-2008 | Ubezio, P; Lupi, M; Natoli, C; Colombo, V; D'Incalci, M | |
| A pharmacological study on pegylated asparaginase used in front-line treatment of children with acute lymphoblastic leukemia | 1-gen-2006 | Rizzari, C; Citterio, M; Zucchetti, M; Conter, V; Chiesa, R; Colombini, A; Malguzzi, S; Silvestri, D; D'Incalci, M | |
| Combination of trabectedin and irinotecan is highly effective in a human rhabdomyosarcoma xenograft | 1-gen-2005 | Riccardi, A; Meco, D; Ubezio, P; Mazzarella, G; Marabese, M; Faircloth, Gt; Jimeno, J; D'Incalci, M; Riccardi, R | |
| Trabectedin as a chemotherapy option for patients with BRCA deficiency | 1-gen-2016 | Monk, Bj; Lorusso, D; Italiano, A; Kaye, Sb; Aracil, M; Tanovic, A; D'Incalci, M | |
| Mechanisms of resistance to alkylating agents | 1-gen-1998 | Damia, G; D'Incalci, M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891